Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase

β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To unde...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 2003-12, Vol.42 (49), p.14483-14491
Hauptverfasser: Roth, Tomer A, Minasov, George, Morandi, Stefania, Prati, Fabio, Shoichet, Brian K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 14491
container_issue 49
container_start_page 14483
container_title Biochemistry (Easton)
container_volume 42
creator Roth, Tomer A
Minasov, George
Morandi, Stefania
Prati, Fabio
Shoichet, Brian K
description β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To understand the origins of this affinity, and to guide design of future inhibitors, double-mutant thermodynamic cycle experiments were undertaken. An unexpected hydrogen bond between the nonconserved Asn289 and a key inhibitor carboxylate was observed in the X-ray crystal structure of a 1 nM inhibitor (compound 1) in complex with AmpC β-lactamase. To investigate the energy of this hydrogen bond, the mutant enzyme N289A was made, as was an analogue of 1 that lacked the carboxylate (compound 2). The differential affinity of the four different protein and analogue complexes indicates that the carboxylate−amide hydrogen bond contributes 1.7 kcal/mol to overall binding affinity. Synthesis of an analogue of 1 where the carboxylate was replaced with an aldehyde led to an inhibitor that lost all this hydrogen bond energy, consistent with the importance of the ionic nature of this hydrogen bond. To investigate the structural bases of these energies, X-ray crystal structures of N289A/1 and N289A/2 were determined to 1.49 and 1.39 Å, respectively. These structures suggest that no significant rearrangement occurs in the mutant versus the wild-type complexes with both compounds. The mutant enzymes L119A and L293A were made to investigate the interaction between a phenyl ring in 1 and these residues. Whereas deletion of the phenyl itself diminishes affinity by 5-fold, the double-mutant cycles suggest that this energy does not come through interaction with the leucines, despite the close contact in the structure. The energies of these interactions provide key information for the design of improved inhibitors against β-lactamases. The high magnitude of the ion−dipole interaction between Asn289 and the carboxylate of 1 is consistent with the idea that ionic interactions can provide significant net affinity in inhibitor complexes.
doi_str_mv 10.1021/bi035054a
format Article
fullrecord <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_bi035054a</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_TPS_XQVJ6M8K_7</sourcerecordid><originalsourceid>FETCH-LOGICAL-a349t-95a7e7db3f0ee891cb3588672a1be824ef222d93cc9f52260e266141d72516f73</originalsourceid><addsrcrecordid>eNptkMtOwzAQRS0EoqWw4AdQNixYBGzHj2QJ5dFCESAKYmdNHKd1aZLKTiXy96RKVTasRjNzNPfOReiU4EuCKblKLY445gz2UJ9wikOWJHwf9THGIqSJwD105P2ibRmW7BD1CBOCtPM-Gk3nxhVV1pRQWB0MG700wXUJy8ZbH0CZBeNyblNbVy64Nd7OygBmYEtfBzemhnACuoYCvDlGBzksvTnZ1gH6uL-bDkfh5OVhPLyehBCxpA4TDtLILI1ybEycEJ1GPI6FpEBSE1NmckpplkRaJzmnVGBDW6uMZJJyInIZDdBFd1e7yntncrVytgDXKILVJg21S6Nlzzp2tU4Lk_2R2_dbIOwA62vzs9uD-1ZCRpKr6eu7-nr7fBTP8ZPaiJ93PGivFtXatUH5f4R_AZN8dFM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase</title><source>MEDLINE</source><source>ACS Publications</source><creator>Roth, Tomer A ; Minasov, George ; Morandi, Stefania ; Prati, Fabio ; Shoichet, Brian K</creator><creatorcontrib>Roth, Tomer A ; Minasov, George ; Morandi, Stefania ; Prati, Fabio ; Shoichet, Brian K</creatorcontrib><description>β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To understand the origins of this affinity, and to guide design of future inhibitors, double-mutant thermodynamic cycle experiments were undertaken. An unexpected hydrogen bond between the nonconserved Asn289 and a key inhibitor carboxylate was observed in the X-ray crystal structure of a 1 nM inhibitor (compound 1) in complex with AmpC β-lactamase. To investigate the energy of this hydrogen bond, the mutant enzyme N289A was made, as was an analogue of 1 that lacked the carboxylate (compound 2). The differential affinity of the four different protein and analogue complexes indicates that the carboxylate−amide hydrogen bond contributes 1.7 kcal/mol to overall binding affinity. Synthesis of an analogue of 1 where the carboxylate was replaced with an aldehyde led to an inhibitor that lost all this hydrogen bond energy, consistent with the importance of the ionic nature of this hydrogen bond. To investigate the structural bases of these energies, X-ray crystal structures of N289A/1 and N289A/2 were determined to 1.49 and 1.39 Å, respectively. These structures suggest that no significant rearrangement occurs in the mutant versus the wild-type complexes with both compounds. The mutant enzymes L119A and L293A were made to investigate the interaction between a phenyl ring in 1 and these residues. Whereas deletion of the phenyl itself diminishes affinity by 5-fold, the double-mutant cycles suggest that this energy does not come through interaction with the leucines, despite the close contact in the structure. The energies of these interactions provide key information for the design of improved inhibitors against β-lactamases. The high magnitude of the ion−dipole interaction between Asn289 and the carboxylate of 1 is consistent with the idea that ionic interactions can provide significant net affinity in inhibitor complexes.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi035054a</identifier><identifier>PMID: 14661960</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Alanine - genetics ; Asparagine - genetics ; Bacterial Proteins ; beta-Lactamase Inhibitors ; beta-Lactamases - chemistry ; beta-Lactamases - genetics ; Binding Sites ; Crystallization ; Crystallography, X-Ray ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Escherichia coli Proteins - antagonists &amp; inhibitors ; Escherichia coli Proteins - chemistry ; Escherichia coli Proteins - genetics ; Hydrogen Bonding ; Leucine - genetics ; Mutagenesis, Site-Directed ; Nuclear Magnetic Resonance, Biomolecular ; Protein Binding ; Recombinant Proteins - antagonists &amp; inhibitors ; Recombinant Proteins - chemical synthesis ; Recombinant Proteins - genetics ; Thermodynamics</subject><ispartof>Biochemistry (Easton), 2003-12, Vol.42 (49), p.14483-14491</ispartof><rights>Copyright © 2003 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a349t-95a7e7db3f0ee891cb3588672a1be824ef222d93cc9f52260e266141d72516f73</citedby><cites>FETCH-LOGICAL-a349t-95a7e7db3f0ee891cb3588672a1be824ef222d93cc9f52260e266141d72516f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi035054a$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi035054a$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2751,27055,27903,27904,56716,56766</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14661960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roth, Tomer A</creatorcontrib><creatorcontrib>Minasov, George</creatorcontrib><creatorcontrib>Morandi, Stefania</creatorcontrib><creatorcontrib>Prati, Fabio</creatorcontrib><creatorcontrib>Shoichet, Brian K</creatorcontrib><title>Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To understand the origins of this affinity, and to guide design of future inhibitors, double-mutant thermodynamic cycle experiments were undertaken. An unexpected hydrogen bond between the nonconserved Asn289 and a key inhibitor carboxylate was observed in the X-ray crystal structure of a 1 nM inhibitor (compound 1) in complex with AmpC β-lactamase. To investigate the energy of this hydrogen bond, the mutant enzyme N289A was made, as was an analogue of 1 that lacked the carboxylate (compound 2). The differential affinity of the four different protein and analogue complexes indicates that the carboxylate−amide hydrogen bond contributes 1.7 kcal/mol to overall binding affinity. Synthesis of an analogue of 1 where the carboxylate was replaced with an aldehyde led to an inhibitor that lost all this hydrogen bond energy, consistent with the importance of the ionic nature of this hydrogen bond. To investigate the structural bases of these energies, X-ray crystal structures of N289A/1 and N289A/2 were determined to 1.49 and 1.39 Å, respectively. These structures suggest that no significant rearrangement occurs in the mutant versus the wild-type complexes with both compounds. The mutant enzymes L119A and L293A were made to investigate the interaction between a phenyl ring in 1 and these residues. Whereas deletion of the phenyl itself diminishes affinity by 5-fold, the double-mutant cycles suggest that this energy does not come through interaction with the leucines, despite the close contact in the structure. The energies of these interactions provide key information for the design of improved inhibitors against β-lactamases. The high magnitude of the ion−dipole interaction between Asn289 and the carboxylate of 1 is consistent with the idea that ionic interactions can provide significant net affinity in inhibitor complexes.</description><subject>Alanine - genetics</subject><subject>Asparagine - genetics</subject><subject>Bacterial Proteins</subject><subject>beta-Lactamase Inhibitors</subject><subject>beta-Lactamases - chemistry</subject><subject>beta-Lactamases - genetics</subject><subject>Binding Sites</subject><subject>Crystallization</subject><subject>Crystallography, X-Ray</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Escherichia coli Proteins - antagonists &amp; inhibitors</subject><subject>Escherichia coli Proteins - chemistry</subject><subject>Escherichia coli Proteins - genetics</subject><subject>Hydrogen Bonding</subject><subject>Leucine - genetics</subject><subject>Mutagenesis, Site-Directed</subject><subject>Nuclear Magnetic Resonance, Biomolecular</subject><subject>Protein Binding</subject><subject>Recombinant Proteins - antagonists &amp; inhibitors</subject><subject>Recombinant Proteins - chemical synthesis</subject><subject>Recombinant Proteins - genetics</subject><subject>Thermodynamics</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkMtOwzAQRS0EoqWw4AdQNixYBGzHj2QJ5dFCESAKYmdNHKd1aZLKTiXy96RKVTasRjNzNPfOReiU4EuCKblKLY445gz2UJ9wikOWJHwf9THGIqSJwD105P2ibRmW7BD1CBOCtPM-Gk3nxhVV1pRQWB0MG700wXUJy8ZbH0CZBeNyblNbVy64Nd7OygBmYEtfBzemhnACuoYCvDlGBzksvTnZ1gH6uL-bDkfh5OVhPLyehBCxpA4TDtLILI1ybEycEJ1GPI6FpEBSE1NmckpplkRaJzmnVGBDW6uMZJJyInIZDdBFd1e7yntncrVytgDXKILVJg21S6Nlzzp2tU4Lk_2R2_dbIOwA62vzs9uD-1ZCRpKr6eu7-nr7fBTP8ZPaiJ93PGivFtXatUH5f4R_AZN8dFM</recordid><startdate>20031216</startdate><enddate>20031216</enddate><creator>Roth, Tomer A</creator><creator>Minasov, George</creator><creator>Morandi, Stefania</creator><creator>Prati, Fabio</creator><creator>Shoichet, Brian K</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20031216</creationdate><title>Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase</title><author>Roth, Tomer A ; Minasov, George ; Morandi, Stefania ; Prati, Fabio ; Shoichet, Brian K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a349t-95a7e7db3f0ee891cb3588672a1be824ef222d93cc9f52260e266141d72516f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Alanine - genetics</topic><topic>Asparagine - genetics</topic><topic>Bacterial Proteins</topic><topic>beta-Lactamase Inhibitors</topic><topic>beta-Lactamases - chemistry</topic><topic>beta-Lactamases - genetics</topic><topic>Binding Sites</topic><topic>Crystallization</topic><topic>Crystallography, X-Ray</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Escherichia coli Proteins - antagonists &amp; inhibitors</topic><topic>Escherichia coli Proteins - chemistry</topic><topic>Escherichia coli Proteins - genetics</topic><topic>Hydrogen Bonding</topic><topic>Leucine - genetics</topic><topic>Mutagenesis, Site-Directed</topic><topic>Nuclear Magnetic Resonance, Biomolecular</topic><topic>Protein Binding</topic><topic>Recombinant Proteins - antagonists &amp; inhibitors</topic><topic>Recombinant Proteins - chemical synthesis</topic><topic>Recombinant Proteins - genetics</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roth, Tomer A</creatorcontrib><creatorcontrib>Minasov, George</creatorcontrib><creatorcontrib>Morandi, Stefania</creatorcontrib><creatorcontrib>Prati, Fabio</creatorcontrib><creatorcontrib>Shoichet, Brian K</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roth, Tomer A</au><au>Minasov, George</au><au>Morandi, Stefania</au><au>Prati, Fabio</au><au>Shoichet, Brian K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>2003-12-16</date><risdate>2003</risdate><volume>42</volume><issue>49</issue><spage>14483</spage><epage>14491</epage><pages>14483-14491</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>β-Lactamases are the most widespread resistance mechanism to β-lactam antibiotics, such as the penicillins and cephalosporins. Transition-state analogues that bind to the enzymes with nanomolar affinities have been introduced in an effort to reverse the resistance conferred by these enzymes. To understand the origins of this affinity, and to guide design of future inhibitors, double-mutant thermodynamic cycle experiments were undertaken. An unexpected hydrogen bond between the nonconserved Asn289 and a key inhibitor carboxylate was observed in the X-ray crystal structure of a 1 nM inhibitor (compound 1) in complex with AmpC β-lactamase. To investigate the energy of this hydrogen bond, the mutant enzyme N289A was made, as was an analogue of 1 that lacked the carboxylate (compound 2). The differential affinity of the four different protein and analogue complexes indicates that the carboxylate−amide hydrogen bond contributes 1.7 kcal/mol to overall binding affinity. Synthesis of an analogue of 1 where the carboxylate was replaced with an aldehyde led to an inhibitor that lost all this hydrogen bond energy, consistent with the importance of the ionic nature of this hydrogen bond. To investigate the structural bases of these energies, X-ray crystal structures of N289A/1 and N289A/2 were determined to 1.49 and 1.39 Å, respectively. These structures suggest that no significant rearrangement occurs in the mutant versus the wild-type complexes with both compounds. The mutant enzymes L119A and L293A were made to investigate the interaction between a phenyl ring in 1 and these residues. Whereas deletion of the phenyl itself diminishes affinity by 5-fold, the double-mutant cycles suggest that this energy does not come through interaction with the leucines, despite the close contact in the structure. The energies of these interactions provide key information for the design of improved inhibitors against β-lactamases. The high magnitude of the ion−dipole interaction between Asn289 and the carboxylate of 1 is consistent with the idea that ionic interactions can provide significant net affinity in inhibitor complexes.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>14661960</pmid><doi>10.1021/bi035054a</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 2003-12, Vol.42 (49), p.14483-14491
issn 0006-2960
1520-4995
language eng
recordid cdi_crossref_primary_10_1021_bi035054a
source MEDLINE; ACS Publications
subjects Alanine - genetics
Asparagine - genetics
Bacterial Proteins
beta-Lactamase Inhibitors
beta-Lactamases - chemistry
beta-Lactamases - genetics
Binding Sites
Crystallization
Crystallography, X-Ray
Enzyme Inhibitors - chemical synthesis
Enzyme Inhibitors - chemistry
Escherichia coli Proteins - antagonists & inhibitors
Escherichia coli Proteins - chemistry
Escherichia coli Proteins - genetics
Hydrogen Bonding
Leucine - genetics
Mutagenesis, Site-Directed
Nuclear Magnetic Resonance, Biomolecular
Protein Binding
Recombinant Proteins - antagonists & inhibitors
Recombinant Proteins - chemical synthesis
Recombinant Proteins - genetics
Thermodynamics
title Thermodynamic Cycle Analysis and Inhibitor Design against Beta-Lactamase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A17%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thermodynamic%20Cycle%20Analysis%20and%20Inhibitor%20Design%20against%20Beta-Lactamase&rft.jtitle=Biochemistry%20(Easton)&rft.au=Roth,%20Tomer%20A&rft.date=2003-12-16&rft.volume=42&rft.issue=49&rft.spage=14483&rft.epage=14491&rft.pages=14483-14491&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi035054a&rft_dat=%3Cistex_cross%3Eark_67375_TPS_XQVJ6M8K_7%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/14661960&rfr_iscdi=true